Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis: A multicenter, double-blind, randomized controlled study.
Joly P, Tejedor I, Tetart F, Cailleux HC, Barrel A, De Preville PA, Mion-Mouton N, Gabison G, Baricault S, Tordeur CG, Dore MX, Rossi B, Bourseau-Quetier C, Chamaillard M, Ly S, Chosidow O, Richard-Lallemand MA, Rzeznik JC, Amici JM, Lair G, Bechu S, Benichou J, Thill C, Beylot-Barry M. Joly P, et al. Among authors: baricault s. J Am Acad Dermatol. 2021 May;84(5):1278-1284. doi: 10.1016/j.jaad.2020.09.055. Epub 2020 Sep 30. J Am Acad Dermatol. 2021. PMID: 33010323 Clinical Trial.
Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: results from a case-control study.
Joly P, Benoit-Corven C, Baricault S, Lambert A, Hellot MF, Josset V, Barbaud A, Courville P, Delaporte E, Collet E, Carvalho P, Modeste-Duval AB, Lacour JP, L'Anthoën-Arditi MH, Thuillez C, Benichou J. Joly P, et al. Among authors: baricault s. J Invest Dermatol. 2007 Dec;127(12):2766-71. doi: 10.1038/sj.jid.5701018. Epub 2007 Aug 23. J Invest Dermatol. 2007. PMID: 17713574 Free article.
Incidence and mortality of bullous pemphigoid in France.
Joly P, Baricault S, Sparsa A, Bernard P, Bédane C, Duvert-Lehembre S, Courville P, Bravard P, Rémond B, Doffoel-Hantz V, Bénichou J. Joly P, et al. Among authors: baricault s. J Invest Dermatol. 2012 Aug;132(8):1998-2004. doi: 10.1038/jid.2012.35. Epub 2012 Mar 15. J Invest Dermatol. 2012. PMID: 22418872 Free article.
[Necrolytic migratory erythema in Waldmann's disease].
Baricault S, Soubrane JC, Courville P, Young P, Joly P. Baricault S, et al. Ann Dermatol Venereol. 2006 Aug-Sep;133(8-9 Pt 1):693-6. doi: 10.1016/s0151-9638(06)70994-2. Ann Dermatol Venereol. 2006. PMID: 17053741 French.
[Tunisian pemphigus foliaceus with antidesmoglein 3 antibody].
Masmoudi A, Baricault S, Chikrouhou H, Zahaf A, Turki H, Abida O, Ben Ayed M, Masmoudi H, Gilbert D, Tron F, Joly P. Masmoudi A, et al. Among authors: baricault s. Ann Dermatol Venereol. 2008 Jan;135(1):69-70. doi: 10.1016/j.annder.2007.04.007. Epub 2008 Jan 18. Ann Dermatol Venereol. 2008. PMID: 18342079 French. No abstract available.
[Severe drug eruption caused by a medication error].
Le Loarer F, Carré-Gislard D, Baricault S, Bravard P. Le Loarer F, et al. Among authors: baricault s. Ann Dermatol Venereol. 2009 Apr;136(4):364-5. doi: 10.1016/j.annder.2008.10.027. Epub 2009 Jan 21. Ann Dermatol Venereol. 2009. PMID: 19361706 French. No abstract available.
Skin lesions of face and scalp - Classification by a market-approved convolutional neural network in comparison with 64 dermatologists.
Haenssle HA, Winkler JK, Fink C, Toberer F, Enk A, Stolz W, Deinlein T, Hofmann-Wellenhof R, Kittler H, Tschandl P, Rosendahl C, Lallas A, Blum A, Abassi MS, Thomas L, Tromme I, Rosenberger A; Reader study level-I and level-II Groups Christina Alt. Haenssle HA, et al. Eur J Cancer. 2021 Feb;144:192-199. doi: 10.1016/j.ejca.2020.11.034. Epub 2020 Dec 25. Eur J Cancer. 2021. PMID: 33370644
Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions.
Haenssle HA, Fink C, Toberer F, Winkler J, Stolz W, Deinlein T, Hofmann-Wellenhof R, Lallas A, Emmert S, Buhl T, Zutt M, Blum A, Abassi MS, Thomas L, Tromme I, Tschandl P, Enk A, Rosenberger A; Reader Study Level I and Level II Groups. Haenssle HA, et al. Ann Oncol. 2020 Jan;31(1):137-143. doi: 10.1016/j.annonc.2019.10.013. Ann Oncol. 2020. PMID: 31912788 Free article.
Risk factors for treatment failure in scabies: a cohort study.
Aussy A, Houivet E, Hébert V, Colas-Cailleux H, Laaengh N, Richard C, Ouvry M, Boulard C, Léger S, Litrowski N, Benichou J, Joly P; investigators from the Normandy Association of Medical Education in Dermatology. Aussy A, et al. Br J Dermatol. 2019 Apr;180(4):888-893. doi: 10.1111/bjd.17348. Epub 2019 Mar 4. Br J Dermatol. 2019. PMID: 30376179
Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
Bénard-Laribière A, Miremont-Salamé G, Pérault-Pochat MC, Noize P, Haramburu F; EMIR Study Group on behalf of the French network of pharmacovigilance centres. Bénard-Laribière A, et al. Fundam Clin Pharmacol. 2015 Feb;29(1):106-11. doi: 10.1111/fcp.12088. Epub 2014 Sep 25. Fundam Clin Pharmacol. 2015. PMID: 24990220
11 results